Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 2001

View Archived Issues

Abgenix discusses first-quarter highlights

Taiwan researchers study plant-derived sesquiterpene as potential antihypertensive agent

Electrophysiological profile of amiodarone homologues examined in guinea pig hearts

Gilead submits MAA for tenofovir DF in Europe

ICN considers licensing levovirin

Pharmacyclics reacquires worldwide rights to Lutrin

Sheffield initiates development of inhaled interferon gamma for respiratory diseases

Phase II trial of irofulven for treatment of glioma commences

Preclinical antiproliferative activity of A-105972 characterized

Antithrombotic activity of agkistin related to platelet gpIb antagonism

Cell Pathways and BMS to initiate drug combination study for first-line NSCLC

Atrix's periodontal disease treatment approved in several European countries

Cathepsin S inhibitor collaboration extended by Medivir, Genzyme; licensing partner sought

Novel approach to therapeutic HBV vaccine taken by StressGen

Sustained benefits seen for Visudyne therapy over three years of follow-up

First quarter at GenVec marked by progress in TNFerade and PEDF programs

Potential new hypnotic Ro-41-3696 tested in multiple-dose clinical study in elderly volunteers

Neurocrine Biosciences reports clinical development progress

Preclinical profile of Bay-59-8862, a new taxane, reviewed in Drugs of the Future

MAbs prepared at Genentech act as HGF receptor antagonists

French lab patents new nicotinic acetylcholine receptor subunit and uses thereof

Novel P2T receptor antagonists identified at AstraZeneca as potential antithrombotics

Theratechnologies and Alza to develop ThGRF in a Macroflux system

Inhibitors of factor Xa under development at Cor Therapeutics

Bayer describes dicarboxylic acid derivatives useful for cardiovascular disorders

Dermatological stilbene compounds in the Galderma pipeline

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...